While in vivo studies have demonstrated the cardioprotective role of miR-150-5p, its expression was significantly downregulated in patients with HF, serving as a predictive biomarker correlated with established HF parameters, such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) [93,94]. The gene discussed is NPPB; the disease is hydrops fetalis.